A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

Hypothesis: Dutasteride will perform better than finasteride in decreasing prostate volume, improving symptoms based on International Prostate Symptom score,and lower pvr based on the scientific information that dutasteride inhibits both Type I and II 5-alpha-reducatase vs. finasteride which only inhibits the Type II enzyme

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Urologic Consultants of Southeastern PA
• Treatments: Dutasteride

Criteria

Inclusion Criteria:

• Male

• Age 50-80

• On finasteride for no less than 12 months

• Willing to undergo all necessary test in the 12 month evaluation

Exclusion Criteria:

• History of medication non-compliance

• Unwillingness to undergo/tolerate 2 blood draws

• Unwillingness to tolerate/undergo 2 TRUSP